What’s Next: Drugmakers Agree to Medicare Drug Price Negotiations

A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the …

Read more

Judge denies request to block; find out the latest update

A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters A federal judge on Friday denied a preliminary injunction sought by the Chamber of Commerce, one of the largest lobbying groups in the country, which aimed to block the …

Read more

Unlocking Affordable Medicare Drug Prices: AstraZeneca and Bristol Myers Squibb’s Negotiations for Affordable Healthcare

In this photo illustration, Farxiga is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images AstraZeneca, Bristol Myers Squibb and Boehringer Ingelheim confirmed their participation in the inaugural Medicare drug price negotiations despite previously filing a lawsuit last month. Among the first …

Read more

Judge recuses herself from Medicare drug price case following disclosure of stock ownership

Ohio Governor Mike DeWine, right, cordially greets Judge Thomas Rose of the U.S. District Court Southern District of Ohio after his inauguration on Monday, Jan. 14, 2019, in Cedarville, Ohio. John Minchillo | AP A federal judge voluntarily recused himself from a case with potential implications on Medicare’s ability to negotiate drug prices. This decision …

Read more

Limited effects anticipated for drugmakers due to Medicare’s drug price negotiations

In this photo illustration, the availability of Eliquis at the New City Halsted Pharmacy in Chicago signals a significant development in Medicare’s effort to negotiate drug prices with manufacturers. The goal is to make expensive treatments more affordable for older Americans. However, the pharmaceutical industry strongly opposes this process. Although these drug price negotiations are …

Read more

Check out the list: 10 medications that will undergo Medicare price negotiations

The Biden administration has unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. The goal of this controversial process is to make expensive medications more affordable for older Americans. The Inflation Reduction Act, passed last year, allows Medicare to directly negotiate drug prices with manufacturers for the …

Read more

Top 10 drugs potentially subjected to autumnal Medicare price negotiations

Merck & Co. Inc.’s Januvia brand medication, used to treat Type 2 diabetes. Daniel Acker | Bloomberg | Getty Images Medicare is set to enter direct negotiations with the pharmaceutical industry this fall to determine drug prices, marking the first time in the program’s history. The Centers for Medicare and Medicaid Services (CMS) will soon …

Read more

Johnson & Johnson Takes Legal Action Against Biden Administration Regarding Medicare Drug Negotiations

Pavlo Gonchar | LightRocket | Getty Images Johnson & Johnson filed a lawsuit against the Biden administration on Tuesday regarding Medicare’s new authority to reduce drug prices. This marks the third pharmaceutical company to challenge this controversial provision of the Inflation Reduction Act. The lawsuit, which was filed in a federal district court in New …

Read more